Phase II study of chemoselection with docetaxel plus cisplatin and 5-fluorouracil induction chemotherapy and subsequent conversion surgery for locally advanced unresectable oesophageal cancer

Randomized study of low-doseversusstandard-dose chemoradiotherapy for unresectable esophageal squamous cell carcinoma (JCOG0303)

(2015) Masayuki Shinoda et al.   CANCER SCIENCE

Esophageal Carcinoma

(2014) Anil K. Rustgi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2013) M. Stahl et al.   ANNALS OF ONCOLOGY

Assessment of Short-Term Clinical Outcomes following Salvage Esophagectomy for the Treatment of Esophageal Malignancy: Systematic Review and Pooled Analysis

(2013) Sheraz R. Markar et al.   ANNALS OF SURGICAL ONCOLOGY

Phase II feasibility study of preoperative chemotherapy with docetaxel, cisplatin, and fluorouracil for esophageal squamous cell carcinoma

(2013) Hiroki Hara et al.   CANCER SCIENCE

Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

(2012) P. van Hagen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients

(2009) Jean-Pierre Pignon et al.   RADIOTHERAPY AND ONCOLOGY

Japanese Classification of Esophageal Cancer, tenth edition: part I

(2009)   Esophagus